Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
CLSA noted that when the RBI gave a one-year extension to the MD of RBL Bank, and later appointed a PSU banker, the stock ...
An analyst from StoxBox said that Yes Bank struggles to hold key support levels and lacks clear directional momentum. The RSI ...